The COVID-19 pandemic has fundamentally changed the deliver way of Canada healthcare system. In Canada，new technological models are being promoted from private to public healthcare providers to pioneer the industry. Digital Therapeutics （DTx），as an innovative tool that leverages digital technologies to drive improvements in medical devices design and healthcare delivery，has largely driven this collaboration and innovation. Market demand for virtual healthcare，an important part of digital therapeutics，is skyrocketing in Canada. In addition，there are many other sub-fields of development opportunities in digital therapeutics，whether it is the digital medicalization of smart devices，a secure way to record images from smart medical diagnostic devices，or new machine learning algorithms for predicting disease and infection outbreaks. Rising levels of Canadians’ satisfaction with digital therapy solutions are creating new，potentially long-term end user habits of healthcare services，such as online bookings，quantified self-visits and virtual visits，which have been honed over a long period of time even pre-COVID-19. The trend of digital therapy in Canada，successful cases in different branches and the rapid development of innovative digital therapy enterprise all demonstrate that the new frontier of medical services has been continuously extended with the development of DTx.